$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Dec 9, 2025)
$655.72M
Market Cap
12.9
P/E Ratio
0.3
EPS
$4.62
52 Week High
$0.40
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
CytomX Therapeutics, Inc. is an innovative biopharmaceutical company headquartered in South San Francisco, California, dedicated to transforming cancer therapies through its proprietary Probody™ technology platform. This cutting-edge approach aims to deliver highly selective treatments that minimize off-tumor effects while maximizing targeted anti-tumor efficacy, thereby addressing significant unmet needs in oncology. With a robust pipeline of product candidates at various clinical stages, CytomX is strategically positioned to enhance patient outcomes and redefine treatment standards in the cancer care landscape. Moreover, the company's focus on strategic partnerships and collaborations bolsters its capacity for impactful advancements within the biopharmaceutical industry.
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
SLM
NVTS
AGNC
NCLH
HOOD
PCG
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
SLM
NVTS
AGNC
NCLH
HOOD
PCG